Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: NOW stock price vs DDS: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DDS's multiple
Needs DDS P/E.
Implied fair value · at NOW's multiple
Needs NOW P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
ServiceNow, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
DILLARD’S, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MICROSOFT CORP
NOW vs MSFT
ADOBE INC.
NOW vs ADBE
ORACLE CORP
NOW vs ORCL
Salesforce, Inc.
NOW vs CRM
INTERNATIONAL BUSINESS MACHINES CORP
NOW vs IBM
Paycom Software, Inc.
NOW vs PAYC
Macy's, Inc.
NOW vs M
KOHLS Corp
NOW vs KSS
TJX COMPANIES INC /DE/
NOW vs TJX
NORDSTROM INC
NOW vs JWN
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Edwyn research
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe NOW can sustain 20.9% revenue growth and 22.0% ROIC long enough to justify a persistent premium, then hold or avoid shorting despite DDS-based downside because the current price is supported by stronger fundamentals than DDS. If you are anchoring to relative valuation or the DCF range of $18.20 to $24.62, the data favor reducing exposure because NOW trades far above both DDS implied price of $25.09 and the DCF range.
The valuation gap is extreme: NOW trades at 63.7x P/E and 8.3x P/S versus DDS at 15.0x P/E and ~0.0x P/S, yet DDS-based implied price is only $25.09 versus NOW's $106.32. That implies the market is paying a large growth/quality premium for NOW, but the model indicates that premium is far above what the DDS multiple would justify.
Supporting Metrics
